VPC
Vestal Point Capital Portfolio holdings
AUM
$1.9B
This Quarter Return
+30.09%
1 Year Return
-12.28%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$944M
AUM Growth
–
Cap. Flow
+$944M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
61.64%
Holding
48
New
48
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$105M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$89.2M |
| 3 |
Ascendis Pharma
ASND
|
$78.7M |
| 4 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$58.1M |
| 5 |
Soleno Therapeutics
SLNO
|
$52.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBIO
26
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $9.05M | 0.96% | +400,000 | New | +$9.05M |
|
27
Regeneron Pharmaceuticals
REGN
$61.5B
| $8.78M | 0.93% | +10,000 | New | +$8.78M |
|
28
Arcutis Biotherapeutics
ARQT
$1.86B
| $8.72M | 0.92% | +2,700,000 | New | +$8.72M |
|
29
Xenon Pharmaceuticals
XENE
$2.98B
| $8.06M | 0.85% | +175,000 | New | +$8.06M |
|
30
Fulcrum Therapeutics
FULC
$351M
| $6.92M | 0.73% | +1,025,000 | New | +$6.92M |
|
31
Alnylam Pharmaceuticals
ALNY
$58.5B
| $6.7M | 0.71% | +35,000 | New | +$6.7M |
|
32
Galapagos
GLPG
$2.07B
| $5.28M | 0.56% | +130,000 | New | +$5.28M |
|
33
Fate Therapeutics
FATE
$120M
| $4.82M | 0.51% | +1,290,000 | New | +$4.82M |
|
34
Cytokinetics
CYTK
$4.23B
| $4.17M | 0.44% | +50,000 | New | +$4.17M |
|
35
Arcellx
ACLX
$3.85B
| $3.33M | 0.35% | +60,000 | New | +$3.33M |
|
|
BLUE
36
DELISTED
bluebird bio
BLUE
| $2.97M | 0.31% | +2,150,000 | New | +$2.97M |
|
37
Teva Pharmaceuticals
TEVA
$21.1B
| $2.09M | 0.22% | +200,000 | New | +$2.09M |
|
38
Dianthus Therapeutics
DNTH
$759M
| $1.4M | 0.15% | +135,000 | New | +$1.4M |
|
|
CMRX
39
DELISTED
Chimerix, Inc.
CMRX
| $1.35M | 0.14% | +1,400,000 | New | +$1.35M |
|
40
Pyxis Oncology
PYXS
$79.4M
| $792K | 0.08% | +440,000 | New | +$792K |
|
|
OKUR
41
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $640K | 0.07% | +400,000 | New | +$640K |
|
|
IMA
42
ImageneBio, Inc. Common Stock
IMA
$150M
| $636K | 0.07% | +322,671 | New | +$636K |
|
43
Relmada Therapeutics
RLMD
$37.2M
| $476K | 0.05% | +115,000 | New | +$476K |
|
|
AFMD
44
DELISTED
Affimed
AFMD
| $341K | 0.04% | +546,067 | New | +$341K |
|
45
Ovid Therapeutics
OVID
$91M
| $275K | 0.03% | +85,429 | New | +$275K |
|
46
Solid Biosciences
SLDB
$427M
| $209K | 0.02% | +34,085 | New | +$209K |
|
47
Prime Medicine
PRME
$578M
| $180K | 0.02% | +20,306 | New | +$180K |
|
|
ACHL
48
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $96.1K | 0.01% | +108,083 | New | +$96.1K |
|